Cardiac outcomes in women receiving aromatase inhibitors as adjuvant endocrine therapy for breast cancer.

被引：1
|
作者：
Park, Esther
Abu-Khalaf, Maysa M.
Hatzis, Christos
LaSala, Johanna M.
Silber, Andrea
Hofstatter, Erin Wysong
Sanft, Tara Beth
Russell, Raymond
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA
[3] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e11501
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11501
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Effect of Tamoxifen and Aromatase Inhibitors on the Risk of Fractures in Women with Breast Cancer.
    Vestergaard, P.
    Rejnmark, L.
    Mosekilde, L.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S297 - S297
  • [42] Non-adherence behaviors among young women on adjuvant endocrine therapy for breast cancer.
    Wassermann, Johanna
    Gelber, Shari I.
    Rosenberg, Shoshana M.
    Ruddy, Kathryn Jean
    Tamimi, Rulla M.
    Schapira, Lidia
    Borges, Virginia F.
    Come, Steven E.
    Partridge, Ann H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [43] ADHERENCE TO TAMOXIFEN AND AROMATASE INHIBITORS AMONG WOMEN WITH INCIDENT BREAST CANCER.
    Nekhlyudov, L.
    Li, L.
    Ross-Degnan, D.
    Wagner, A.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 15 - 16
  • [44] No Correlation between Endocrine Symptoms and Musculoskeletal Symptoms in Women Receiving Adjuvant Aromatase Inhibitor Therapy
    Cigler, T.
    Singer, O.
    Moore, A.
    Chuang, E.
    Vandat, L.
    Reichman, B.
    Levine, A. B.
    Do, H. T.
    Mandl, L. A.
    CANCER RESEARCH, 2010, 70
  • [45] Neuropsychological Functioning in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitor Therapy
    Weaver, J. R.
    Stark, S. M.
    Shaverdi, K. T.
    Jeter, S.
    Zorzi, J.
    Skolasky, R. L.
    Andrejczuk, M. A.
    Sterans, V
    Gordon, B.
    CLINICAL NEUROPSYCHOLOGIST, 2011, 25 (05) : 883 - 883
  • [46] Aromatase inhibitors in adjuvant setting in breast cancer
    Spano, JP
    Khayat, D
    Delozier, T
    BULLETIN DU CANCER, 2004, 91 : S239 - S243
  • [47] Aromatase inhibitors as adjuvant treatment of breast cancer
    Geisler, J
    Lonning, PE
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 57 (01) : 53 - 61
  • [48] Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy
    Mousa, Noha A.
    Crystal, Pavel
    Wolfman, Wendy L.
    Bedaiwy, Mohamed A.
    Casper, Robert F.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (05): : 875 - 884
  • [49] Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
    Ellis, Georgiana K.
    Bone, Henry G.
    Chlebowski, Rowan
    Paul, Devchand
    Spadafora, Silvana
    Smith, Judy
    Fan, Michelle
    Jun, Susie
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (30) : 4875 - 4882
  • [50] Predictors and temporal trends of adjuvant endocrine therapy use in breast cancer.
    Svahn, TH
    Niland, JC
    Hughes, ME
    Ottesen, RA
    Theriault, RL
    Edge, SB
    Schott, AF
    Bookman, MA
    Weeks, JC
    Carlson, RW
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S105 - S105
12345